InVivo Therapeutics Holdings Corp
NVIV
Get informed when a big investor buys or sells
+ FollowMarket Cap$995.92K
Close$
Share Statistics
| Market cap | $995,918.00 |
|---|---|
| Enterprise Value | $-7,585,082.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-6.62 |
| Beta | 0.66 |
| Outstanding Shares | 3,106,000 |
Return
| Return on Equity | -100.73% |
|---|---|
| Return on Assets | -93.73% |
| Return on Invested Capital | -109.86% |
Valuation & Multiples
| P/E Ratio | -0.05 |
|---|---|
| PEG | -4.03 |
| Price to Sales | - |
| Price to Book Ratio | 0.16 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.77 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About InVivo Therapeutics Holdings Corp
CEO: Richard Toselli